| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 03/22/2007 | US20070066607 5-[R-2-(1S,2S-2-Cyclohexylcyclopentylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one, useful for treating conditions that are prevented or alleviated by activation of the adrenergic recptors |
| 03/22/2007 | US20070066606 Benzylbenzimidazolyl derivatives |
| 03/22/2007 | US20070066596 Pesticidal 5-substituted-oxalkylamino-1-arylpyrazole derivatives |
| 03/22/2007 | US20070066591 Compounds for treatment of cell proliferation disorder and prevention of kinesins |
| 03/22/2007 | US20070066590 Phenyl-and pyridylpiperidine-derivatives as modulators of glucose metabolism |
| 03/22/2007 | US20070066588 Benzothiazole cyclobutyl amine derivatives |
| 03/22/2007 | US20070066587 Substituted azetidine compounds, their preparation and use as medicaments |
| 03/22/2007 | US20070066583 Monocyclic and bicyclic compounds and methods of use |
| 03/22/2007 | US20070066577 Benzoxazole derivative or analogue thereof for inhibiting 5-lipoxygenase and pharmaceutical composition containing same |
| 03/22/2007 | US20070066573 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors |
| 03/22/2007 | US20070066488 Hetaryl-substituted pyrazolidindione derivatives with pesticidal characteristics |
| 03/22/2007 | CA2622518A1 Thiazolinones and oxazolinones and their use as ptp1b inhibitors |
| 03/22/2007 | CA2621364A1 Biphenyl derivatives and their use in treating hepatitis c |
| 03/22/2007 | CA2621292A1 1-2-dihydroquinoline derivative having glucocorticoid receptor binding actvity |
| 03/22/2007 | CA2619059A1 Pesticide thiazolyloxy substituted phenylamidine derivatives |
| 03/22/2007 | CA2617394A1 2-aniline-4-aryl substituted thiazole derivatives |
| 03/21/2007 | EP1764366A2 Thrombin receptor antagonists |
| 03/21/2007 | EP1764362A1 Biaryl derivatives |
| 03/21/2007 | EP1764358A2 Cyclic amides as vanilloid receptor ligands and their use in treatments of inflammatory and neuropathic pain |
| 03/21/2007 | EP1764134A2 Tetrahydroindolone and purine derivatives linked to arylpiperazines |
| 03/21/2007 | EP1763524A1 Indole derivatives and use thereof as kinase inhibitors |
| 03/21/2007 | EP1763303A1 Substituted pyridazine carboxamides and derivatives thereof |
| 03/21/2007 | EP1345943B1 Inhibitors of papilloma virus |
| 03/21/2007 | CN1934108A Polymorphic form B2 of ziprasidone base |
| 03/21/2007 | CN1934107A 2-(3-substituted-aryl)amino-4-aryl-thiazoles as tyrosine kinase inhibitors |
| 03/21/2007 | CN1934105A Aryl-substituted heterocycles, process for their preparation and their use as medicaments |
| 03/21/2007 | CN1934100A Substituted quinazoline or pyridopyrimidine derivative |
| 03/21/2007 | CN1934099A N-piperidine derivates as CCR3 modulators |
| 03/21/2007 | CN1934094A Diaryl-substituted five-membered heterocycle derivative |
| 03/21/2007 | CN1934091A Imidazole compounds for the treatment of neurodegenerative disorders |
| 03/21/2007 | CN1934088A 6-substituted 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 03/21/2007 | CN1934083A 2,7-substituted 5-amino-4-hydroxy-8-(1h-indol-5-yl)-octan amide derivatives as renin inhibitors for the treatment of hypertension |
| 03/21/2007 | CN1933839A Compounds and methods of use |
| 03/21/2007 | CN1933838A Bipyridyl amides as modulators of metabotropic glutamate receptor-5 |
| 03/21/2007 | CN1933833A Aqueous composition comprising thiazole derivative |
| 03/21/2007 | CN1933832A Ion channel modulators |
| 03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
| 03/21/2007 | CN1305872C Process for producing quinazoline ditosylate salt compounds |
| 03/21/2007 | CN1305862C 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 03/21/2007 | CN1305858C Substituted azole compounds and their preparation and application |
| 03/21/2007 | CN1305852C Diaryl ethers as opioid receptor antagonist |
| 03/21/2007 | CN1305847C 1,3-disubstituted pyrrolidines as alpha-2-adrenoceptor antagonists |
| 03/20/2007 | US7193065 activated haptens useful for generating immunogens to HIV protease inhibitors |
| 03/20/2007 | US7192979 EP4 receptor selective agonist in the treatment of osteoporosis |
| 03/20/2007 | US7192978 Pyrrolidinium derivatives |
| 03/20/2007 | US7192973 Piperidine derivatives and their use as modulators of chemokine receptor activity (especially CCR5) |
| 03/20/2007 | US7192968 Ethylenediamine derivatives |
| 03/20/2007 | US7192967 Cyclic imide-substituted pyridylalkane, alkene, alkine carboxamides useful as cytostatic and immunosuppressive agents |
| 03/20/2007 | US7192961 1-Carbonyl-4-(4-quinoline-)-piperazine or 1-carbonyl-4-[4-(1H-quinolin-2-{thio}one)-piperazine derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 03/20/2007 | US7192957 3-Azabicyclo[3.1.0]hexane derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus; AIDS |
| 03/20/2007 | US7192955 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/20/2007 | US7192950 Psychological disorders; eating disorders; dietetics |
| 03/20/2007 | US7192949 Anticarcinogenic and antiproliferative agents |
| 03/20/2007 | US7192946 Hyperlipemia agents; bile acid transport inhibitors |
| 03/20/2007 | US7192945 Benzothiazepine derivatives |
| 03/20/2007 | CA2211320C 5-methanesulfonamido-3h-isobenzofuran-1-ones as inhibitors of cyclooxygenase-2 |
| 03/15/2007 | WO2007030618A2 Bicyclic derivatives as modulators of voltage gated ion channels |
| 03/15/2007 | WO2007029587A1 β SECRETASE INHIBITOR |
| 03/15/2007 | WO2007029076A1 Isoindole derivatives as antimicrobial agents |
| 03/15/2007 | WO2007029037A2 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | WO2007029036A2 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007029035A2 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | WO2007029021A1 1,5-substituted tetrazoles as therapeutic compounds |
| 03/15/2007 | WO2007028999A1 Thiazole compounds and their use as pgd2 antagonists |
| 03/15/2007 | WO2007028520A1 Iminooxazolidine derivatives and use thereof |
| 03/15/2007 | WO2007028445A1 6-indolyl-4-yl-amino-5-halogeno-2-pyrimidinyl-amino derivatives |
| 03/15/2007 | WO2007016674A3 2-aminoaryl pyridines as protein kinases inhibitors |
| 03/15/2007 | WO2007002220A3 Aminoacetamide acyl guanidines as beta-secretase inhibitors |
| 03/15/2007 | WO2006128692A3 2-oxo-1-pyrrolidine derivatives and their therapeutic use on the central nervous system |
| 03/15/2007 | WO2006106437A8 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors |
| 03/15/2007 | WO2006024823A9 Pyrimidine sulphonamide derivatives as chemokine receptor modulators |
| 03/15/2007 | US20070060753 Process for preparing intermediates useful to prepare certain antibacterial n-formyl hydroxylamines |
| 03/15/2007 | US20070060752 1-Phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases |
| 03/15/2007 | US20070060628 Use of 5-[4-(6-methoxy-1-methyl-1H-benzimidazol-2-ylmethoxy)benzyl] thiazolidine-2,4-dione |
| 03/15/2007 | US20070060626 5-{4-[4-Methyl-2-(4-trifluoromethyl-phenyl)-thiazol-5-ylmethoxy]-phenyl}-3H-[1,3,4]oxadiazol-2-one; agonists and antiagonists; demylination diseases; metabolic diseases; antidiabetic agents (type 2); syndrom X; asthma; osteoarthritis; lupus; antiinflammatory agents; cardiovascular disorders; cachexia |
| 03/15/2007 | US20070060618 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 03/15/2007 | US20070060616 Methods for treating, preventing and managing chronic lymphocytic leukemia with indazole compounds |
| 03/15/2007 | US20070060606 Compounds and methods for modulating phosphodiesterase 10A |
| 03/15/2007 | US20070060591 Amine substituted (dihydro- or tetrahydro-)quinoline, pyranopyridine, thiapyranopyridine, or naphthyridine derivatives as chemokine receptor modulators; lymphadenopathy associated, human T-cell leukemia/lymphoma, and/or feline immunodeficiency virus infections |
| 03/15/2007 | US20070060590 osteoporosis and fracture; Prostaglandin E2 derivatives specially EP4 receptor agonists; ethyl 3-{4-[(2-{3-oxo-4-[3-(trifluoromethyl)phenyl]butyl}-6-oxotetrahydropyridazin-1-yl)methyl]phenyl}acrylate |
| 03/15/2007 | US20070060589 Inhibitors of protein arginine methyl transferases |
| 03/15/2007 | US20070060584 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers |
| 03/15/2007 | US20070060582 1,4-Disubstituted isoquinilone derivatives as raf-kinase inhibitors useful for the treatment of proliferative diseases |
| 03/15/2007 | US20070060573 Acyltryptophanols |
| 03/15/2007 | US20070060571 e.g. 4-(5-(4-Chlorophenyl)-3-((nitrooxy)methyl)-3-hydropyrazolyl)benzenesulfonamide and nitric oxide donor (S-nitrosothiols, nitrites, nitrates, N-oxo-N-nitrosamines, sabstrate of nitric oxide synthase); analgesics, antiinflammatory agent, wound healing; gastrointestinal disorders; side effect reduction |
| 03/15/2007 | US20070060569 Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors |
| 03/15/2007 | US20070060566 Benzazepine derivatives as histamine h3 antagonists |
| 03/15/2007 | CA2622076A1 Bicyclic derivatives as modulators of voltage gated ion channels |
| 03/15/2007 | CA2621448A1 Class iia histone deacetylase (hdac) substrate |
| 03/15/2007 | CA2621445A1 Amino acid derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621443A1 Thiophene and thiazole substituted trifluoroethanone derivatives as histone deacetylase (hdac) inhibitors |
| 03/15/2007 | CA2621406A1 Pparactive compounds |
| 03/15/2007 | CA2621390A1 Iminooxazolidine derivatives and use thereof |
| 03/14/2007 | EP1762568A1 Pyrazole derivatives |
| 03/14/2007 | EP1761526A2 Thiazole derivatives as chemokine receptor antagonists |
| 03/14/2007 | EP1761522A1 Compounds and methods for treating dyslipidemia |
| 03/14/2007 | EP1761518A1 Novel alkyl substituted piperidine derivatives as monoamine neurotransmitter re-uptake inhibitors |
| 03/14/2007 | EP1761516A1 2, 4, 5, 6-substituted pyrimidines, method for the production and use thereof for combating parasitic fungi |
| 03/14/2007 | EP1761506A1 Substituted quinazolones as anti-cancer agents |
| 03/14/2007 | EP1761497A2 Azadecalin glucocorticoid receptor modulators |